00069-0231 Lorbrena - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

00069-0231

Brand Name:

Lorbrena

Generic Name:

Lorlatinib

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: LORLATINIB

Strength: 100.0

Unit: mg/1

Packages:

Code: 00069-0231-01

Description: 30 TABLET, FILM COATED in 1 BOTTLE (0069-0231-01)

Effective Date: Nov. 19, 2018

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

ALK/ROS1

Orphan Drug Designation:

Status:

In Use